The breakthrough in weight-loss medication has shaken the healthcare trade. Goldman Sachs Analysis expects weight-loss medication to spice up U.S. gross home product (GDP) by 0.4% in a baseline situation with 30 million customers and drive a 1% rise when customers attain 60 million. Additional, Goldman Sachs expects the weight-loss medication market to succeed in...
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
LLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?
You may also like
Contact Information
- Do not hesitate to contact us if you have questions about the subscription or your ads publish. We are here to help!
- E-mail at [email protected]
- Give us a call at our toll-free number: ((888) 503-2390